BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 13354260)

  • 1. Interaction of convertin with platelets and with platelet-free and hemophilic plasma.
    DE VRIES A; KREJNIS E; SHAFRIR E
    Acta Haematol; 1956 Sep; 16(3):204-13. PubMed ID: 13354260
    [No Abstract]   [Full Text] [Related]  

  • 2. Prothrombin utilization following addition of platelet confactor I concentrates to hemophilic plasma.
    JOHNSON JF; MAMMEN EF; SEEGERS WH
    Thromb Diath Haemorrh; 1959 Sep; 3():588-92. PubMed ID: 14407473
    [No Abstract]   [Full Text] [Related]  

  • 3. Clotting of hemophilic blood with purified platelet cofactor I, platelet factor 3 and threone.
    SEEGERS WH; LANDABURU RH; HOLBURN RR; TOCANTINS LM
    Proc Soc Exp Biol Med; 1957 Jul; 95(3):583-5. PubMed ID: 13453515
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombelastographic observations on the characteristics of hemophilic, thrombocytopenic and heparinized blood.
    DE NICOLA P; MAZZETTI GM
    Blood; 1956 Jan; 11(1):71-80. PubMed ID: 13276486
    [No Abstract]   [Full Text] [Related]  

  • 5. Clotting defect in hemophilia; deficiency in a plasma factor required for thromboplastin liberation from platelets.
    BRINKHOUS KM
    Fed Proc; 1947; 6(1):389. PubMed ID: 20343817
    [No Abstract]   [Full Text] [Related]  

  • 6. Antihemophilic factor (AHF): plasma levels after administration of AHF preparations to hemophilic dogs.
    WAGNER RH; LANGDELL RD; RICHARDSON BA; FARRELL RA; BRINKHOUS KM
    Proc Soc Exp Biol Med; 1957 Oct; 96(1):152-5. PubMed ID: 13485042
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the incomplete correction of the hemophilic hemocoagulative error on the part of conductor blood. Thromboelastographic observations].
    GIACCA S; NEGRINI AC
    Arch Maragliano Patol Clin; 1959 Aug; 15():1071-80. PubMed ID: 13827794
    [No Abstract]   [Full Text] [Related]  

  • 8. Concurrent hemophilia and qualitative platelet disturbance.
    DJERASSI I; DE VRIES A; FISHER I; REMEZ D
    Acta Haematol; 1957 Nov; 18(5):354-8. PubMed ID: 13487188
    [No Abstract]   [Full Text] [Related]  

  • 9. [Research on the antithromboplastin factors in hemophilia. 1. The plasma antithromboplastin of Tocantins].
    CHEVALLIER P; FIEHRER A; BILSKI-PASQUIER G; SAMAMA M
    Sang; 1955; 26(4):362-76. PubMed ID: 13246570
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of aspirin on the blood platelets in children].
    Nakasawa S; Yamada Z; Yamada K
    Nihon Shonika Gakkai Zasshi; 1971 Oct; 75(10):932-7. PubMed ID: 5317038
    [No Abstract]   [Full Text] [Related]  

  • 11. The inhibitory effect of haemophilic plasma.
    BIGGS R
    Br J Haematol; 1958 Apr; 4(2):192-200. PubMed ID: 13536256
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of blood coagulation in hemophilia].
    FRANCESCON M; BUTTO M; MASETTO I
    Riforma Med; 1953 Aug; 67(34):942-5. PubMed ID: 13101410
    [No Abstract]   [Full Text] [Related]  

  • 13. The antihaemophilic-globulin concentration in the plasma of female carriers of haemophilia.
    GARDIKAS C; KATSIROUMBAS P; KOTTAS C
    Br J Haematol; 1957 Oct; 3(4):377-8. PubMed ID: 13479686
    [No Abstract]   [Full Text] [Related]  

  • 14. The influence of hydergine on the coagulation time in hemophilia.
    SIMONOVIC I
    Acta Haematol; 1955 Aug; 14(2):96-9. PubMed ID: 13258141
    [No Abstract]   [Full Text] [Related]  

  • 15. Bridge anticoagulant; a hitherto unrecognized blood clotting inhibitor in haemophilic and Christmas-disease plasma; a simple method for its demonstration.
    NOUR-ELDIN F; WILKINSON JF
    Br J Haematol; 1958 Jan; 4(1):38-50. PubMed ID: 13499832
    [No Abstract]   [Full Text] [Related]  

  • 16. Activation of purified prothrombin with hemophilic plasma.
    JOHNSON SA
    Am J Clin Pathol; 1953 Sep; 23(9):875-80. PubMed ID: 13092058
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of incubation on the anthemophilic globulin of adsorbed plasma and of adsorbed plasma-serum mixture. Absence of true consumption of the anthemophilic globulin and of development of a thromboplastin-accelerator power].
    MAYER G; MAYER S
    C R Seances Soc Biol Fil; 1961; 155():653-6. PubMed ID: 14471691
    [No Abstract]   [Full Text] [Related]  

  • 18. On demonstration of the haemophilic conductor, especially by determination of the coagulation time.
    SJØLIN KE
    Acta Pathol Microbiol Scand; 1954; 35(6):512-22. PubMed ID: 13228064
    [No Abstract]   [Full Text] [Related]  

  • 19. Nature of the blood clotting mechanisms in hemophilia.
    JOHNSON SA; McCLAUGHRY RI; SEEGERS WH
    J Mich State Med Soc; 1955 Jul; 54(7):797-800. PubMed ID: 13243059
    [No Abstract]   [Full Text] [Related]  

  • 20. Atypical blood clotting patterns in hemophilia.
    SPAET TH; KINSELL B; BEHRING HM; AGGELER PM
    Stanford Med Bull; 1953 May; 11(2):118-23. PubMed ID: 13076908
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.